Cat#:RP-1012H;Product Name:Recombinant Human LRG1 Protein;Synonym:HMFT1766,LRG;Description:A DNA sequence encoding the human LRG1 (AAH34389.1) (Met1-Gln347) was expressed with six amino acids (LEVLFQ) at the C-terminus.;Source:Human Cells;Predicted N Terminal:Val 36;Molecular Characterization:The recombinant human LRG1 is a disulfide-linked homodimer. The reduced monomer comprises 319 amino acids and has a predicted molecular mass of 35.1 kDa. The apparent molecular mass of the protein is approximately 45 kDa in SDS-PAGE under reducing conditi;Purity:Greater than 95 % as determined by SDS-PAGE;Endotoxin:< 1.0 EU per ug of the protein as determined by the LAL method;Bioactivity:Please contact us for detailed information;Formulation:Lyophilized from sterile PBS, pH 7.4.;Stability:Recombinant Proteins are stable for up to 1 year from date of receipt at -70℃;Reconstitution:Please see related COA for specific instructions.;Storage:Avoid repeated freeze-thaw cycles. In lyophilized state for 1 year (4-8℃); Upon reconstitution under sterile conditions for 2 weeks (4-8℃) or 3 months (-20℃ to -70℃).;
A DNA sequence encoding the human LRG1 (AAH34389.1) (Met1-Gln347) was expressed with six amino acids (LEVLFQ) at the C-terminus.
Source:
Human Cells
Predicted N Terminal:
Val 36
Molecular Characterization:
The recombinant human LRG1 is a disulfide-linked homodimer. The reduced monomer comprises 319 amino acids and has a predicted molecular mass of 35.1 kDa. The apparent molecular mass of the protein is approximately 45 kDa in SDS-PAGE under reducing conditi
Purity:
Greater than 95 % as determined by SDS-PAGE
Endotoxin:
< 1.0 EU per ug of the protein as determined by the LAL method
Bioactivity:
Please contact us for detailed information
Formulation:
Lyophilized from sterile PBS, pH 7.4.
Stability:
Recombinant Proteins are stable for up to 1 year from date of receipt at -70℃
Reconstitution:
Please see related COA for specific instructions.
Storage:
Avoid repeated freeze-thaw cycles. In lyophilized state for 1 year (4-8℃); Upon reconstitution under sterile conditions for 2 weeks (4-8℃) or 3 months (-20℃ to -70℃).